ANURAS price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- ANURAS
- MB Code
- MBEQU288
- ISIN
- INE930P01018
- BSE code
- 543275
- Industry group
- Chemicals & Petrochemicals
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 635.78 Cr
- Net profit
- 56 Cr
- EPS
- 3.75
- YoY revenue
- +27.12%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for ANURAS
Anupam Rasayan approved buying up to 74.2% of Bliss GVS Pharma for about ₹1,369 crore, including an open offer, to expand from KSMs into …
Anupam Rasayan has acquired Jayhawk Fine Chemicals for $150 million, enhancing its global presence and diversifying its portfolio. The de…
Anupam Rasayan announced a $150 million acquisition of Jayhawk Fine Chemicals, expected to enhance its US presence and product portfolio.…
Anupam Rasayan India has agreed to acquire Jayhawk Fine Chemicals Corp for $150 million, marking its entry into US manufacturing. The dea…
Anupam Rasayan's Q2 net profit soared 87% to Rs 57.2 crore, up from Rs 30.6 crore last year. Revenue also jumped to Rs 739.2 crore from R…
EPS 3.93 vs est. 2.32
Beat estimates by 69.18%
Anupam Rasayan India Ltd's consolidated net sales for September 2025 reached Rs 731.40 crore, reflecting a 148.81% year-on-year increase,…
Dividend of ₹0.75 per share
Ex-date corporate action
Price returns
Historical performance
Technicals
Indicator consensus